Among 28 randomised controlled trials, weight was no different between treatment and control groups 1.4 years after cessation of WMM
On the other hand, there are no data to indicate that long-term, 'controlled' use of illicit drugs directly affects the risk or benefit of HCV treatment, which therefore should be considered based on the HCV genotype, stage of the disease, and other factors, as in persons not using illicit drugs
While compounded oral tirzepatide is not FDA-approved and isn't covered by insurance, options like Oral Wegovy and Foundayo, as well as injectable forms like Zepbound for weight management, are generally covered, provided they meet specific health criteria
A_User February 25, 2025, 8:32am #10 See IGF-1 inhibitor aging studies in dogs as well or other animals, and IGF-1 deficiency dwarfism